Results 251 to 260 of about 167,856 (315)

Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors. [PDF]

Int J Mol Sci
Mavridis E, Hadjipavlou-Litina D.
europepmc   +1 more source

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension. [PDF]

J Am Heart Assoc
Wu W, Kong F, Chen Z, Huang L, Nie X, Bian JS.   +5 more
europepmc   +1 more source

Novel 2-substituted benzothiazole derivatives: synthesis, <i>in vitro</i> and <i>in silico</i> evaluations as potential anticancer agents. [PDF]

RSC Adv
Azzam RA, Seif MM, El-Demellawy MA, Elgemeie GH.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Membrane receptors with protein-tyrosine kinase activity

Biochimie, 1987
Protein-tyrosine kinase activities have appeared so far to be intrinsic for two classes of proteins: the transforming proteins of certain retroviral oncogenes and the membrane receptors for certain cellular growth factors. In this latter family, the protein-tyrosine kinase is activated upon binding of the growth factor to its receptor and ...
J J, Feige, E M, Chambaz
openaire   +2 more sources

src-related protein tyrosine kinases and their surface receptors

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
The CD4-p56lck and CD8-p56lck complexes have served as a paradym for an expanding number of interactions between src-family members (p56lck, p59fyn, p56lyn, p55blk) and surface receptors. These interactions implicate src-related kinases in the regulation of a variety of intracellular events, from lymphokine production and cytotoxicity to the expression
Telfer, Janice T., Rudd, C.E., Janssen, O., Prasad, K.V.S., Raab, M., Dasilva, A., Yamamoto, H.   +6 more
openaire   +2 more sources